EquityZen Growth Technology Fund LLC - Series 1689
Raised
$574K
Investors
27
Min Invest
$10,009
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1689 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC and Philip Haslett on 2023-05-16. The fund raised $574K from 27 investors under Rule 506(b) and Section 3(c)(1) exemptions, with a $10K minimum investment. It is part of the EquityZen platform, which operates nearly 1,900 related pre-IPO investment entities.
This pre-IPO fund utilizes the standard 506(b)/3(c)(1) exemption combination typical of retail-accessible private growth equity vehicles, with a $10K minimum positioning it at the mass-affluent entry tier. The sub-$1M raise and 27-investor count reflect a single-company exposure SPV common in secondary marketplace platforms.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
